m-DASC: Measuring Subjective Effects of Very Low Doses of Psychedelic Drugs
Psychedelic Medicine · 01.03.2026 · 4 (1) · 81-88
DOI: 10.1177/28314425251404476 ↗Kurz gefasst
Fachartikel in der Zeitschrift Psychedelic Medicine, online erschienen am 05.12.2025. Verfasst von Jonah Griffin-Stolbach und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Behavioral Neuroscience, The University of Chicago, Chicago, Illinois, USA. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA.
Abstract (Originalsprache)
Background
There has been great interest in the use of very low doses of psychedelic drugs like lysergic acid diethylamide (LSD) to improve mood and cognition. However, controlled studies have thus far provided little support for their efficacy. One challenge is that the subjective effects are subtle and on the threshold of detectability, whereas the questionnaires used to assess the drugs’ effects were designed for very high, psychedelic doses. Using confirmatory factor analyses, we showed that both the Five-Dimensional Altered States of Consciousness Questionnaire (5D-ASC) and the 11-factor Altered States of Consciousness Rating Scale do not represent the underlying structure of responses to very low doses of LSD.
Methods
To address this gap, we conducted a principal component analysis to identify items from previous questionnaires suited to low doses, using data from 199 healthy volunteers who received 6.5, 13, and 26 µg doses of LSD under controlled conditions. Using items from the 5D-ASC, we developed the micro -dimensional Altered States of Consciousness (m-DASC), consisting of four components corresponding to Transcendent Experience, Auditory Somatic Disturbance, Animated Intoxication, and Synesthesia.
Results
The m-DASC is substantially shorter than existing questionnaires (31 items). It accounted for 44% of the variance in the dataset used, showed significant effects of LSD at the 26 and 13 µg doses, and was highly correlated with the original longer questionnaires.
Conclusions
The m-DASC is likely to be of value in future studies investigating the subjective effects of very low doses of psychedelic drugs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychiatry and Behavioral Neuroscience, The University of Chicago, Chicago, Illinois, USA.
- Department of Public Health Science, University of Chicago, Chicago, Illinois, USA.
ORCID-Profile: Harriet de Wit
Förderung
- NIDA
Zitieren
APA
Griffin-Stolbach, J., Molla, H., Hedeker, D., & de Wit, H. (2026). m-DASC: Measuring Subjective Effects of Very Low Doses of Psychedelic Drugs. Psychedelic Medicine, 4(1), 81-88. https://doi.org/10.1177/28314425251404476
Vancouver
Griffin-Stolbach J, Molla H, Hedeker D, de Wit H. m-DASC: Measuring Subjective Effects of Very Low Doses of Psychedelic Drugs. Psychedelic Medicine. 2026;4(1):81-88. doi:10.1177/28314425251404476
BibTeX
@article{GriffinStolbach2026,
author = {Griffin-Stolbach, Jonah and Molla, Hanna and Hedeker, Donald and de Wit, Harriet},
title = {m-DASC: Measuring Subjective Effects of Very Low Doses of Psychedelic Drugs},
journal = {Psychedelic Medicine},
year = {2026},
volume = {4},
number = {1},
pages = {81--88},
doi = {10.1177/28314425251404476}
}
EUVIMED